SEATTLE and VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and ...
Jacobs highlighted Achieve’s redevelopment of this drug into a novel treatment for nicotine addiction, now known as cytisinicline. This new cytisinicline product features a revised formulation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback